U.S. Genetic Testing Market to Reach USD 10.29 Billion with 13.0% CAGR by 2027 backed by the Increasing Awareness Regarding Testing Efficacy Amongst Healthcare Professionals, says Fortune Business Insights™

Top Players Covered in the U.S. Genetic Testing Market Research Report Are Invitae Corporation (San Francisco, U.S.), Ambry Genetics (Aliso Viejo, U.S.), BioReference Laboratories, Inc. (Elmwood Park, U.S.), Progenity, Inc. (San Diego, U.S.), Quest Diagnostics Incorporated (Secaucus, U.S.), Myriad Genetics, Inc. (Salt Lake City, U.S.), Fulgent Genetics (Temple City, U.S.), Burning Rock Biotech Limited (Guangzhou, China) and other key market players.


Pune, India, March 24, 2021 (GLOBE NEWSWIRE) -- The U.S. genetic testing market size is expected to gain momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of 13.0% between 2020 and 2027. This information is published by Fortune Business Insights in its latest report, titled, “U.S. Genetic Testing Market, 2020-2027.” The report further mentions that the market stood at USD 4.11 billion in 2019. Factors such as increasing prevalence of chronic disorders and the increasing awareness regarding the efficacy of genetic testing in the U.S. will contribute to the growth of the market during the forecast period.

What does the Report Provide?

The market report provides a qualitative and quantitative analysis of the market and focuses on key aspects such as the regulatory overview, key industry developments such as mergers, acquisitions, and partnerships, and funding raised by start-up companies that will impact the market. Additionally, the report offers valuable insights into the latest market trends and highlights key industry dynamics by adopting several research methodologies during the forecast period.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/u-s-genetic-testing-market-105034


Market to Exhibit 6.7% Growth in 2020 amid COVID-19

The market for genetic testing in the U.S. is expected to register a lower growth by exhibiting a CAGR of 6.7% in 2020. Factors such as cancellation and postponement of non-essential diagnostics such as that of hereditary disease and cancer screening and more impetus on COVID-19 screening is expected to lead to sluggish growth of the market. However, favorable government policies and proactive steps to widen the reach of screening amongst patients by the companies is expected to contribute to the growth of the U.S. Genetic Testing Market in the forthcoming years.


Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034


Increasing Prevalence of Chronic Disorders to Augment Growth

According to the Centers for Disease Control and Prevention (CDC), chronic ailments such as cancer, heart disorders, and diabetes are the leading cause of disability and deaths of people across the U.S. Moreover, the U.S. healthcare system suffers an estimated USD 320 billion annually, in direct and indirect costs. Therefore, to reduce the healthcare costs, several healthcare companies contemplate offering advanced screening solutions to detect the disease at the preliminary stage and further prevent disease fatality. Moreover, increasing awareness regarding the efficacy of the genetic testing methods amongst the healthcare professionals is expected to favor the U.S. genetic testing market growth in the forthcoming years.


Quick Buy - U.S. Genetic Testing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/105034


Partnership between Major Companies to Amplify Their Market Positions

The market is fragmented by the presence of major companies such as Myriad Genetics and Quest Diagnostics trying to maintain a stronghold by partnering other companies to expand their product portfolio. Moreover, the other companies such as Ambry Genetics, Invitae Corporation, and BioReference Laboratories are adopting strategies such as merger and acquisition to maintain their presence and gain a competitive edge over their rivals in the forthcoming years.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-genetic-testing-market-105034


List of the Companies Profiled in the Market:

  • Invitae Corporation (San Francisco, U.S.)
  • Ambry Genetics (Aliso Viejo, U.S.)
  • BioReference Laboratories, Inc. (Elmwood Park, U.S.)
  • Progenity, Inc. (San Diego, U.S.)
  • Quest Diagnostics Incorporated (Secaucus, U.S.)
  • Myriad Genetics, Inc. (Salt Lake City, U.S.)
  • Fulgent Genetics (Temple City, U.S.)
  • Burning Rock Biotech Limited (Guangzhou, China)


Some major points from Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Regulatory Overview
    • Overview: Funding Raised by Genetic Testing focused Start-up Companies
    • Key Industry Developments - Mergers, Acquisitions, and Partnership
    • Porter’s Five Forces Analysis
    • SWOT Analysis
    • Impact of COVID-19 Pandemic on the U.S. Genetic Testing Market
    • Analysis of Transactions in the Molecular Diagnostic Clinical Laboratory Market
    • Overview: Personalized Medicine Market Size (USD billion), U.S., 2019
    • Reimbursement Scenario
  • U.S. Genetic Testing Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Technique
      • PCR
      • DNA Sequencing
      • Microarrays
      • Others
    • Market Analysis, Insights and Forecast – By Application
      • Cardiology
      • Oncology
      • Pharmacogenomics
      • Cognitive Dysfunction
      • Pathogenomics
      • Others
    • Market Analysis, Insights and Forecast – By Payer
      • Public Health Insurance
      • Private Health Insurance
      • Out-of-Pocket
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals
      • Independent Laboratories
  • Competitive Analysis
    • U.S. Market Share Analysis (2019)
    • Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
      • Invitae Corporation
      • Ambry Genetics
      • BioReference Laboratories, Inc.
      • Progenity, Inc.
      • PathemaGX
      • Quest Diagnostics Incorporated
      • Myriad Genetics, Inc.
      • Fulgent Genetics
      • Burning Rock Biotech Limited


Continued...


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/u-s-genetic-testing-market-105034


Have a Look at Related Reports:

Medical Imaging Market Size, Share & COVID-19 Impact Analysis, Type (Magnetic Resonance Imaging, Computed Tomography, X-ray, Ultrasound and Molecular Imaging), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, and Others), and Regional Forecast, 2020-2027

mHealth Apps Market Size, Share & Industry Analysis, By App Type (Disease & Treatment Management, Wellness Management, Others), By Application (Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Others), By Operating System Type (Google Play Store, Apple App Store, Others) and Regional Forecast, 2019-2026

Pain Management Devices Market Size, Share and Industry Analysis By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Regional Forecast, 2019 – 2026

Diabetic Ulcer Treatment Market Size, Share and Covid-19 Impact Analysis, By Ulcer Type (Foot Ulcer (Neuropathic Ulcer, Ischemic Ulcer, and Neuro-ischemic Ulcer), Mouth Ulcer, and Others), By Treatment Type (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2020-2027

Reading Glasses Market Size, Share & Industry Analysis, By Age Group (Less than 18 years, 18-64 years, and 65 years and above), By Type (Prescription Reading Glasses and OTC Reading Glasses), By Distribution Channel (Retail Stores, Online Sales Channels, Ophthalmol-ogy Clinics), and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs